NASDAQ:GUTS Fractyl Health (GUTS) Stock Price, News & Analysis $0.72 -0.01 (-1.08%) Closing price 04:00 PM EasternExtended Trading$0.74 +0.01 (+1.67%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Fractyl Health Stock (NASDAQ:GUTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Fractyl Health alerts:Sign Up Key Stats Today's Range$0.70▼$0.7450-Day Range$0.45▼$0.9552-Week Range$0.38▼$2.45Volume605,424 shsAverage Volume3.97 million shsMarket Capitalization$114.85 millionP/E RatioN/ADividend YieldN/APrice Target$5.40Consensus RatingHold Company Overview Fractyl Health, Inc. is a clinical-stage medical technology company focused on the development and commercialization of minimally invasive, endoscopic therapies for metabolic diseases. Headquartered in Lexington, Massachusetts, Fractyl is advancing treatments that target the underlying physiology of conditions such as type 2 diabetes, obesity and nonalcoholic fatty liver disease (NAFLD) by modifying the duodenal mucosa to improve metabolic control. The company’s lead product, Revita® Duodenal Mucosal Resurfacing (Revita DMR), employs a catheter-based hydrothermal ablation technique to remodel the lining of the upper small intestine. This outpatient procedure is designed to interrupt disease-driving signals between the gut and the liver, pancreas and brain, with the aim of improving glycemic control and reducing liver fat. Fractyl has conducted multiple clinical trials across North America, Europe and Asia, and holds CE mark approval in the European Union for Revita DMR. Fractyl Health is also developing next-generation therapies and combination approaches to expand the reach of its duodenal resurfacing technology. The company has initiated pivotal studies to support U.S. regulatory filings and is preparing for broader commercial roll-out following anticipated approvals. Fractyl’s management team includes industry veterans in interventional gastroenterology, clinical development and medical device commercialization, positioning the company to address the growing global burden of metabolic disease.AI Generated. May Contain Errors. Read More Fractyl Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks82nd Percentile Overall ScoreGUTS MarketRank™: Fractyl Health scored higher than 82% of companies evaluated by MarketBeat, and ranked 138th out of 863 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingHold Consensus RatingFractyl Health has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialFractyl Health has a consensus price target of $5.40, representing about 634.7% upside from its current price of $0.74.Amount of Analyst CoverageFractyl Health has only been the subject of 3 research reports in the past 90 days.Read more about Fractyl Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Fractyl Health are expected to grow in the coming year, from ($0.60) to ($0.53) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fractyl Health is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fractyl Health is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioFractyl Health has a P/B Ratio of 10.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Fractyl Health's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.66% of the float of Fractyl Health has been sold short.Short Interest Ratio / Days to CoverFractyl Health has a short interest ratio ("days to cover") of 1.54, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Fractyl Health has recently decreased by 22.12%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldFractyl Health does not currently pay a dividend.Dividend GrowthFractyl Health does not have a long track record of dividend growth. News and Social Media2.3 / 5News Sentiment0.69 News SentimentFractyl Health has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Fractyl Health this week, compared to 3 articles on an average week.Search InterestOnly 9 people have searched for GUTS on MarketBeat in the last 30 days. This is a decrease of -10% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Fractyl Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership3.2 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $13,800.00 in company stock, which represents 0.0118% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Fractyl Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $13,800.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders8.52% of the stock of Fractyl Health is held by insiders.Percentage Held by InstitutionsFractyl Health has minimal institutional ownership at this time.Read more about Fractyl Health's insider trading history. Receive GUTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fractyl Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GUTS Stock News HeadlinesFractyl Health Stockholders Back Board and Auditor at Meeting11 minutes ago | tipranks.comFractyl Health (NASDAQ:GUTS) CFO Purchases $13,800.00 in StockJune 10 at 6:26 AM | insidertrades.comJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before major runs - says the window to get in early is closing fast. Brown is showing investors how to claim a stake in Elon Musk's company before it hits the public markets. Once the IPO happens, this pre-public opportunity disappears.June 11 at 1:00 AM | Brownstone Research (Ad)Fractyl Health, Inc. (NASDAQ:GUTS) Given Average Recommendation of "Hold" by AnalystsJune 10 at 4:17 AM | americanbankingnews.comFractyl Health Highlights One-Year Revita Obesity ResultsJune 4, 2026 | tipranks.comFractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® ProcedureJune 4, 2026 | globenewswire.comFractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial StrategyJune 1, 2026 | globenewswire.comFractyl Health (GUTS) Is Up 14.0% After First GLP-1 Gene Therapy Trial Win And Profit TurnaroundMay 16, 2026 | finance.yahoo.comSee More Headlines GUTS Stock Analysis - Frequently Asked Questions How have GUTS shares performed this year? Fractyl Health's stock was trading at $2.20 on January 1st, 2026. Since then, GUTS stock has decreased by 66.6% and is now trading at $0.7350. How were Fractyl Health's earnings last quarter? Fractyl Health, Inc. (NASDAQ:GUTS) released its quarterly earnings results on Tuesday, May, 12th. The company reported $0.06 EPS for the quarter, beating the consensus estimate of ($0.17) by $0.23. Read the conference call transcript. When did Fractyl Health IPO? Fractyl Health (GUTS) raised $110 million in an IPO on Friday, February 2nd 2024. The company issued 7,333,333 shares at a price of $14.00-$16.00 per share. Who are Fractyl Health's major shareholders? Fractyl Health's top institutional shareholders include Pale Fire Capital SE (3.73%), Maverick Capital Ltd. (2.51%), Bank of America Corp DE (0.08%) and OMERS ADMINISTRATION Corp (0.08%). Insiders that own company stock include Ajay Royan, Harith Rajagopalan, Jay David Caplan, Weber Lara Smith and William Bradley. View institutional ownership trends. How do I buy shares of Fractyl Health? Shares of GUTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Fractyl Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Fractyl Health investors own include SoFi Technologies (SOFI), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Alphabet (GOOG), JPMorgan Chase & Co. (JPM) and Advanced Micro Devices (AMD). Company Calendar Last Earnings5/12/2026Today6/11/2026Next Earnings (Estimated)8/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 GUTS's financial health is in the Green zone, according to TradeSmith. GUTS has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryMedical Equipment Current SymbolNASDAQ:GUTS Previous SymbolNASDAQ:GUTS CIK1572616 Webfractyl.com Phone781-902-8800FaxN/AEmployees102Year Founded2010Price Target and Rating Average Price Target for Fractyl Health$5.40 High Price Target$8.00 Low Price Target$2.00 Potential Upside/Downside+646.0%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($1.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$140.95 million Net MarginsN/A Pretax Margin-4,073,233.50% Return on Equity-4,053.15% Return on Assets-96.41% Debt Debt-to-Equity Ratio1.41 Current Ratio4.28 Quick Ratio4.28 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.07 per share Price / Book10.34Miscellaneous Outstanding Shares158,649,000Free Float145,132,000Market Cap$114.85 million OptionableN/A Beta2.34 Social Links Beginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:GUTS) was last updated on 6/11/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fractyl Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fractyl Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
